Bridgeway Capital Management’s cbdMD YCBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-751
Closed -$61K 1469
2022
Q3
$61K Sell
751
-57
-7% -$8.18K ﹤0.01% 1334
2022
Q2
$128K Sell
808
-208
-20% -$49.3K ﹤0.01% 1182
2022
Q1
$380K Sell
1,016
-884
-47% -$299K 0.01% 1013
2021
Q4
$739K Sell
1,900
-801
-30% -$466K 0.01% 865
2021
Q3
$2.02M Buy
2,701
+288
+12% +$241K 0.04% 617
2021
Q2
$2.52M Buy
2,413
+305
+14% +$365K 0.05% 528
2021
Q1
$3.14M Sell
2,108
-181
-8% -$263K 0.06% 429
2020
Q4
$2.43M Buy
2,289
+835
+57% +$759K 0.05% 458
2020
Q3
$1.05M Buy
1,454
+750
+107% +$716K 0.02% 663
2020
Q2
$484K Buy
704
+652
+1,254% +$293K 0.01% 868
2020
Q1
$17K Sell
52
-234
-82% -$92.3K ﹤0.01% 1253
2019
Q4
$233K Buy
+286
New +$343K ﹤0.01% 1173

Other funds holding YCBD

Bridgeway Capital Management's YCBD Position: Q4 2022 in Review

Bridgeway Capital Management sold out of cbdMD (YCBD) in Q4 2022, closing a stake of 751 shares — an estimated $61K sold.

Bridgeway Capital Management first reported a position in YCBD in Q4 2019 and held it in 12 quarters. The position peaked at $3.14M in Q1 2021. 43 funds tracked by Wall St. Rank hold YCBD as of Q4 2022.

  • Bridgeway Capital Management reported no remaining cbdMD position as of Q4 2022 after selling out during the quarter.
  • Bridgeway Capital Management sold 751 cbdMD shares in Q4 2022, an estimated $61K.
  • Bridgeway Capital Management first reported a position in cbdMD in Q4 2019 and held it in 12 quarters.
  • Bridgeway Capital Management's cbdMD position peaked at $3.14M in Q1 2021.
  • 43 funds tracked by Wall St. Rank held cbdMD as of Q4 2022.

Based on Bridgeway Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.